| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.9M | -13.2% |
| SG&A Expense | $5.4M | -1.4% |
| Operating Income | -$17.1M | -12.0% |
| Pre-tax Income | -$4.0M | +73.7% |
| Net Income | -$4.0M | +73.7% |
| EPS (Basic) | -$5.33 | -1266.7% |
| EPS (Diluted) | -$5.33 | +54.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | +257.9% |
| Short-term Investments | $2.2M | -45.1% |
| Current Assets | $5.8M | +7.7% |
| Total Assets | $17.9M | +1.8% |
| Current Liabilities | $5.0M | +80.1% |
| Total Liabilities | $5.1M | +78.9% |
| Stockholders' Equity | $12.4M | -15.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | -5.8% |
| Investing Cash Flow | $1.8M | -73.3% |
| Financing Cash Flow | $13.1M | +135.4% |